Delivery Order SPE2DB20D3304-SPE2DB25FW5C3

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,079.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $2,309.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat hypertension. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $1,945.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a cardiovascular medication, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,890.24 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,873.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of telmisartan-amlodipine 80-10 30s, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,531.37 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Telmisartan 80 mg tablets. The $2,277.04 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,508.49 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, with a completion date of January 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,437.93 firm fixed price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication, to support military treatment facilities and other federal medical institutions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.44 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW5C3
    Delivery Order

This federal contract award, valued at $2,495.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Telmisartan 80 mg tablets, a cardiovascular medication, and does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely part of the company's broader contractual relationship with the DLA, demonstrating its critical role in supplying essential medical commodities to federal government agencies, particularly within the military and veterans' healthcare systems.

Generated 4/21/25, 3:52 AM